Seattle Cannabis Company Capitalizes on Surging Demand
The increase in the number of states that permit recreational and medical use of cannabis means that growers, processors and manufacturers of cannabis products often can’t keep up with growing demand. One Seattle weed manufacturer is poised to sell products across state lines, easing shortages. This could drive the company’s shares sky-high.
Get all the details on this potential blockbuster!

PTGX Insider Trading (Protagonist Therapeutics)

Insider Ownership Percentage: 5.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $730,920.60

Protagonist Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Protagonist Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Protagonist Therapeutics Share Price & Price History

Current Price: $42.94
Price Change: Price Decrease of -0.33 (-0.76%)
As of 06/24/2021 12:58 PM ET

This chart shows the closing price history over time for PTGX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Seattle Cannabis Company Capitalizes on Surging Demand
The increase in the number of states that permit recreational and medical use of cannabis means that growers, processors and manufacturers of cannabis products often can’t keep up with growing demand. One Seattle weed manufacturer is poised to sell products across state lines, easing shortages. This could drive the company’s shares sky-high.
Get all the details on this potential blockbuster!

Protagonist Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/10/2021Sarah B NoonbergDirectorSell4,700$25.47$119,709.004,700View SEC Filing Icon  
1/19/2021Dinesh V Ph D PatelCEOSell24,846$24.60$611,211.60450,990View SEC Filing Icon  
3/12/2020Harold E SelickDirectorBuy12,000$6.70$80,400.0015,310View SEC Filing Icon  
12/3/2019Bryan GiraudoDirectorBuy8,000$5.70$45,600.0010,000View SEC Filing Icon  
12/3/2019Donald A KalkofenCFOBuy1,175$5.10$5,992.50613View SEC Filing Icon  
12/3/2019Suneel GuptaEVPBuy30,000$5.13$153,900.00389,824View SEC Filing Icon  
8/6/2019David Y. LiuInsiderSell3,395$8.85$30,045.75View SEC Filing Icon  
8/6/2019Dinesh V. Ph D. PatelCEOSell10,792$8.85$95,509.20View SEC Filing Icon  
3/1/2019Dinesh V Ph D PatelCEOSell2,183$8.03$17,529.49386,014View SEC Filing Icon  
3/1/2019Richard S ShamesInsiderSell657$8.03$5,275.7132,678View SEC Filing Icon  
2/6/2019David Y LiuInsiderSell3,821$7.74$29,574.5437,007View SEC Filing Icon  
2/6/2019Dinesh V Ph D PatelCEOSell10,909$7.74$84,435.66367,396View SEC Filing Icon  
See Full Table
Insider Selling at Protagonist Therapeutics?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Protagonist Therapeutics and related companies.

SEC Filings (Institutional Ownership Changes) for Protagonist Therapeutics (NASDAQ:PTGX)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PTGX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Protagonist Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/24/2021Principal Financial Group Inc.8,176$0.21M0.0%N/A0.019%Search for SEC Filing on Google Icon
5/20/2021Axiom Investment Management LLC46,800$1.22M0.3%N/A0.106%Search for SEC Filing on Google Icon
5/19/2021Twin Lakes Capital Management LLC142,884$3.70M2.3%+0.3%0.325%Search for SEC Filing on Google Icon
5/18/2021BVF Inc. IL3,959,451$102.55M3.8%-7.4%9.010%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC10,892$0.28M0.0%-52.2%0.025%Search for SEC Filing on Google Icon
5/18/2021Canada Pension Plan Investment Board55,000$1.43M0.0%N/A0.125%Search for SEC Filing on Google Icon
5/18/2021Opaleye Management Inc.297,000$7.69M1.1%+14.2%0.676%Search for SEC Filing on Google Icon
5/18/2021Point72 Asset Management L.P.942,300$24.41M0.1%+71.3%2.144%Search for SEC Filing on Google Icon
5/18/2021D. E. Shaw & Co. Inc.200,980$5.21M0.0%-40.3%0.457%Search for SEC Filing on Google Icon
5/18/2021State of Wisconsin Investment Board53,700$1.39M0.0%-3.1%0.122%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley4,723$0.12M0.0%-85.9%0.011%Search for SEC Filing on Google Icon
5/18/2021Cubist Systematic Strategies LLC14,700$0.38M0.0%N/A0.033%Search for SEC Filing on Google Icon
5/18/2021California State Teachers Retirement System53,123$1.38M0.0%+11.5%0.121%Search for SEC Filing on Google Icon
5/17/2021Deerfield Management Company L.P. Series C1,258,790$32.60M0.7%-8.8%2.864%Search for SEC Filing on Google Icon
5/17/2021AQR Capital Management LLC30,387$0.79M0.0%+29.7%0.069%Search for SEC Filing on Google Icon
5/17/2021Royal Bank of Canada3,324$86K0.0%+179.3%0.008%Search for SEC Filing on Google Icon
5/17/2021Price T Rowe Associates Inc. MD913,590$23.66M0.0%+8.1%2.079%Search for SEC Filing on Google Icon
5/17/2021Ameriprise Financial Inc.28,488$0.74M0.0%-57.4%0.065%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC144,700$1.12M0.0%+28.5%0.329%Search for SEC Filing on Google Icon
5/17/2021Sphera Funds Management LTD.202,134$5.24M0.4%N/A0.460%Search for SEC Filing on Google Icon
5/17/2021Atom Investors LP30,542$0.79M0.1%-69.4%0.070%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.414,134$10.73M0.0%-24.9%0.942%Search for SEC Filing on Google Icon
5/14/2021Laurion Capital Management LP147,405$3.82M0.0%+13.3%0.335%Search for SEC Filing on Google Icon
5/14/2021Kennedy Capital Management Inc.75,518$1.96M0.0%N/A0.172%Search for SEC Filing on Google Icon
5/14/2021Birchview Capital LP10,000$0.26M0.2%N/A0.023%Search for SEC Filing on Google Icon
5/14/2021RTW Investments LP3,507,390$90.84M1.4%-3.9%7.981%Search for SEC Filing on Google Icon
5/14/2021Dimensional Fund Advisors LP656,101$16.98M0.0%+1.0%1.493%Search for SEC Filing on Google Icon
5/14/2021TD Asset Management Inc.61,471$1.59M0.0%+19.9%0.140%Search for SEC Filing on Google Icon
5/14/2021UBS Asset Management Americas Inc.25,000$0.65M0.0%+104.9%0.057%Search for SEC Filing on Google Icon
5/14/2021Dynamic Technology Lab Private Ltd8,202$0.21M0.0%-19.3%0.019%Search for SEC Filing on Google Icon
5/14/2021Credit Suisse AG21,240$0.55M0.0%-58.2%0.048%Search for SEC Filing on Google Icon
5/14/2021Rothschild & Co. Asset Management US Inc.434,249$11.25M0.1%N/A0.988%Search for SEC Filing on Google Icon
5/14/2021O Shaughnessy Asset Management LLC2,206$57K0.0%N/A0.005%Search for SEC Filing on Google Icon
5/13/2021Trexquant Investment LP10,522$0.27M0.0%-41.8%0.024%Search for SEC Filing on Google Icon
5/13/2021Axiom Investment Management LLC46,800$1.22M0.2%N/A0.106%Search for SEC Filing on Google Icon
5/13/2021SG Americas Securities LLC8,725$0.23M0.0%N/A0.020%Search for SEC Filing on Google Icon
5/13/2021Barclays PLC37,866$0.98M0.0%+257.0%0.086%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp133,595$3.46M0.0%+3.3%0.304%Search for SEC Filing on Google Icon
5/13/2021Citigroup Inc.95,720$2.48M0.0%+886.1%0.218%Search for SEC Filing on Google Icon
5/13/2021Bank of Montreal Can90,073$2.40M0.0%-32.6%0.205%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp415,513$10.76M0.0%+2.9%0.946%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC645,679$16.72M0.0%+27.0%1.469%Search for SEC Filing on Google Icon
5/12/2021Prudential Financial Inc.33,615$0.87M0.0%-23.3%0.076%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.584,897$15.15M0.0%-16.8%1.331%Search for SEC Filing on Google Icon
5/12/2021Panagora Asset Management Inc.229,513$5.94M0.0%-3.0%0.522%Search for SEC Filing on Google Icon
5/12/2021E Fund Management Co. Ltd.3,162$82K0.0%N/A0.007%Search for SEC Filing on Google Icon
5/12/2021Sei Investments Co.86,880$2.25M0.0%N/A0.198%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG44,573$1.15M0.0%-31.4%0.101%Search for SEC Filing on Google Icon
5/11/2021Vontobel Holding Ltd.10,000$0.26M0.0%N/A0.023%Search for SEC Filing on Google Icon
5/10/2021Russell Investments Group Ltd.50,733$1.31M0.0%-7.9%0.115%Search for SEC Filing on Google Icon
5/10/2021Kestra Advisory Services LLC13,629$0.35M0.0%N/A0.031%Search for SEC Filing on Google Icon
5/10/2021State Board of Administration of Florida Retirement System8,630$0.22M0.0%N/A0.020%Search for SEC Filing on Google Icon
5/10/2021Principal Financial Group Inc.8,176$0.21M0.0%N/A0.019%Search for SEC Filing on Google Icon
5/10/2021Rafferty Asset Management LLC75,976$1.97M0.0%+447.6%0.173%Search for SEC Filing on Google Icon
5/10/2021Obermeyer Wood Investment Counsel Lllp386,072$10M0.6%N/A0.879%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.3,001,629$77.74M0.0%+15.8%6.830%Search for SEC Filing on Google Icon
5/7/2021American International Group Inc.20,527$0.53M0.0%+12.2%0.047%Search for SEC Filing on Google Icon
5/7/2021BNP Paribas Arbitrage SA4,638$0.12M0.0%-36.9%0.011%Search for SEC Filing on Google Icon
5/7/2021Swiss National Bank83,600$2.17M0.0%+1.1%0.190%Search for SEC Filing on Google Icon
5/6/2021Arizona State Retirement System10,644$0.28M0.0%N/A0.024%Search for SEC Filing on Google Icon
5/6/2021Rhumbline Advisers33,215$0.86M0.0%-1.5%0.076%Search for SEC Filing on Google Icon
5/6/2021Alliancebernstein L.P.30,600$0.79M0.0%+9.3%0.070%Search for SEC Filing on Google Icon
5/6/2021Altium Capital Management LP238,354$6.17M1.7%+28.2%0.542%Search for SEC Filing on Google Icon
5/5/2021Los Angeles Capital Management LLC47,387$1.23M0.0%-1.3%0.108%Search for SEC Filing on Google Icon
5/4/2021Bingham Osborn & Scarborough LLC15,640$0.41M0.0%-39.0%0.036%Search for SEC Filing on Google Icon
5/3/2021The Manufacturers Life Insurance Company20,039$0.52M0.0%+5.4%0.046%Search for SEC Filing on Google Icon
4/28/2021Lindbrook Capital LLC3,200$83K0.0%+166.7%0.007%Search for SEC Filing on Google Icon
3/12/2021DekaBank Deutsche Girozentrale14,000$0.30M0.0%N/A0.037%Search for SEC Filing on Google Icon
3/8/2021Dimensional Fund Advisors LP649,540$13.10M0.0%-5.2%1.698%Search for SEC Filing on Google Icon
3/2/2021Norges Bank11,160$0.23M0.0%N/A0.029%Search for SEC Filing on Google Icon
3/1/2021UBS Asset Management Americas Inc.12,200$0.25M0.0%N/A0.032%Search for SEC Filing on Google Icon
2/26/2021Twin Lakes Capital Management LLC142,483$2.87M2.1%N/A0.372%Search for SEC Filing on Google Icon
2/25/2021Dimensional Fund Advisors LP649,540$13.10M0.0%-5.2%1.698%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC11,887$0.24M0.0%N/A0.031%Search for SEC Filing on Google Icon
2/19/2021JPMorgan Chase & Co.703,007$14.17M0.0%-10.4%1.838%Search for SEC Filing on Google Icon
2/17/2021Jane Street Group LLC14,473$0.29M0.0%+9.1%0.038%Search for SEC Filing on Google Icon
2/16/2021Silverarc Capital Management LLC20,910$0.42M0.2%N/A0.055%Search for SEC Filing on Google Icon
2/16/2021Squarepoint Ops LLC16,893$0.34M0.0%N/A0.044%Search for SEC Filing on Google Icon
2/16/2021Tri Locum Partners LP259,283$5.23M1.9%N/A0.678%Search for SEC Filing on Google Icon
2/16/2021Baker BROS. Advisors LP1,436,192$28.95M0.1%-10.0%3.754%Search for SEC Filing on Google Icon
2/16/2021Nuveen Asset Management LLC112,571$0.87M0.0%-0.6%0.294%Search for SEC Filing on Google Icon
2/16/2021Price T Rowe Associates Inc. MD845,395$17.04M0.0%+44.3%2.210%Search for SEC Filing on Google Icon
2/16/2021Engineers Gate Manager LP13,030$0.26M0.0%N/A0.034%Search for SEC Filing on Google Icon
2/16/2021Gyon Technologies Capital Management LP74,652$1.51M0.5%N/A0.195%Search for SEC Filing on Google Icon
2/16/2021ExodusPoint Capital Management LP15,701$0.32M0.0%N/A0.041%Search for SEC Filing on Google Icon
2/16/2021Charles Schwab Investment Management Inc.225,220$4.54M0.0%+4.0%0.589%Search for SEC Filing on Google Icon
2/12/2021Opaleye Management Inc.260,000$7.02M0.9%N/A0.680%Search for SEC Filing on Google Icon
2/12/2021Laurion Capital Management LP130,158$2.62M0.0%N/A0.340%Search for SEC Filing on Google Icon
2/12/2021Federated Hermes Inc.42,992$0.87M0.0%+40,844.8%0.112%Search for SEC Filing on Google Icon
2/12/2021The Manufacturers Life Insurance Company19,015$0.38M0.0%+10.8%0.050%Search for SEC Filing on Google Icon
2/12/2021Credit Suisse AG50,823$1.03M0.0%+85.0%0.133%Search for SEC Filing on Google Icon
2/12/2021Virtus ETF Advisers LLC14,102$0.28M0.1%-26.0%0.037%Search for SEC Filing on Google Icon
2/11/2021Lazard Asset Management LLC2,607$52K0.0%N/A0.007%Search for SEC Filing on Google Icon
2/11/2021Trexquant Investment LP18,074$0.36M0.0%N/A0.047%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp403,717$8.14M0.0%+5.0%1.055%Search for SEC Filing on Google Icon
2/11/2021Bingham Osborn & Scarborough LLC25,640$0.52M0.0%N/A0.067%Search for SEC Filing on Google Icon
2/11/2021Barclays PLC10,608$0.21M0.0%-27.0%0.028%Search for SEC Filing on Google Icon
2/11/2021Citigroup Inc.9,707$0.20M0.0%+302.6%0.025%Search for SEC Filing on Google Icon
2/11/2021Dynamic Technology Lab Private Ltd10,162$0.21M0.0%N/A0.027%Search for SEC Filing on Google Icon
2/11/2021Monashee Investment Management LLC70,000$1.41M0.2%N/A0.183%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Protagonist Therapeutics logo
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. It is developing PTG-300, an injectable hepcidin mimetic that is in Phase II clinical trial for the treatment of patients with polycythemia vera and hereditary hemochromatosis, as well as for the treatment of other blood disorders; PTG-200, an oral, interleukin-23 receptor specific antagonist peptide, which is in phase II clinical trial for the treatment of moderate-to-severe Crohn's disease; and PN-943, an oral, alpha-4-beta-7 specific integrin antagonist that is in Phase II clinical trial for treating inflammatory bowel disease (IBD). The company has a license and collaboration agreement with Janssen Biotech, Inc. for the development, manufacture, and commercialization of PTG-200 for the treatment of Crohn's disease and ulcerative colitis; and PN-235 and PN-232 oral interleukin-23 receptor antagonist candidates for IBD and non-IBD indications. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.
Read More on Protagonist Therapeutics

Today's Range

Now: $42.94
Low: $42.56
High: $44.10

50 Day Range

MA: $33.20
Low: $26.10
High: $43.44

52 Week Range

Now: $42.94
Low: $14.16
High: $44.37

Volume

7,091 shs

Average Volume

386,169 shs

Market Capitalization

$1.89 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.56

Who are the company insiders with the largest holdings of Protagonist Therapeutics?

Protagonist Therapeutics' top insider investors include:
  1. Dinesh V Ph D Patel (CEO)
  2. Suneel Gupta (EVP)
  3. Harold E Selick (Director)
  4. Bryan Giraudo (Director)
  5. Sarah B Noonberg (Director)
  6. Donald A Kalkofen (CFO)
  7. David Y Liu (Insider)
  8. Dinesh V Ph D Patel (CEO)

Who are the major institutional investors of Protagonist Therapeutics?

Protagonist Therapeutics' top institutional shareholders include:
  1. BVF Inc. IL — 9.01%
  2. RTW Investments LP — 7.98%
  3. BlackRock Inc. — 6.83%
  4. Deerfield Management Company L.P. Series C — 2.86%
  5. Point72 Asset Management L.P. — 2.14%
  6. Price T Rowe Associates Inc. MD — 2.08%

Which major investors are selling Protagonist Therapeutics stock?

Within the previous quarter, PTGX stock was sold by these institutional investors:
  1. BVF Inc. IL
  2. RTW Investments LP
  3. Goldman Sachs Group Inc.
  4. D. E. Shaw & Co. Inc.
  5. Deerfield Management Company L.P. Series C
  6. JPMorgan Chase & Co.
  7. Atom Investors LP
  8. Bank of Montreal Can
During the previous year, company insiders that have sold Protagonist Therapeutics company stock include:
  1. Dinesh V Ph D Patel (CEO)
  2. Suneel Gupta (EVP)

Which major investors are buying Protagonist Therapeutics stock?

Within the last quarter, PTGX stock was bought by institutional investors including:
  1. Rothschild & Co. Asset Management US Inc.
  2. BlackRock Inc.
  3. Point72 Asset Management L.P.
  4. Obermeyer Wood Investment Counsel Lllp
  5. Sphera Funds Management LTD.
  6. Geode Capital Management LLC
  7. Sei Investments Co.
  8. Citigroup Inc.
During the last year, these company insiders have bought Protagonist Therapeutics stock:
  1. Dinesh V Ph D Patel (CEO)
  2. Suneel Gupta (EVP)
  3. Harold E Selick (Director)
  4. Bryan Giraudo (Director)
Seattle Cannabis Company Capitalizes on Surging Demand
The increase in the number of states that permit recreational and medical use of cannabis means that growers, processors and manufacturers of cannabis products often can’t keep up with growing demand. One Seattle weed manufacturer is poised to sell products across state lines, easing shortages. This could drive the company’s shares sky-high.
Get all the details on this potential blockbuster!